<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-9933</journal-id>
<journal-title><![CDATA[Revista Información Científica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. inf. cient.]]></abbrev-journal-title>
<issn>1028-9933</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas Guantánamo]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-99332024000100025</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad renal crónica y factores de progresión en pacientes con diabetes mellitus tipo 2]]></article-title>
<article-title xml:lang="en"><![CDATA[Chronic kidney disease and progression factors in patients with type 2 diabetes mellitus]]></article-title>
<article-title xml:lang="pt"><![CDATA[Doença renal crônica e fatores de progressão em pacientes com diabetes mellitus tipo 2]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Batista Téllez]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Estrada Hernández]]></surname>
<given-names><![CDATA[José Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morell Pérez]]></surname>
<given-names><![CDATA[Leobel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Docente Clínico Quirúrgico Dr. Miguel Enríquez  ]]></institution>
<addr-line><![CDATA[ La Habana]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital General Docente Vladimir Ilich Lenin  ]]></institution>
<addr-line><![CDATA[ Holguín]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Estatal Amazónica  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>103</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-99332024000100025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-99332024000100025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-99332024000100025&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La enfermedad renal crónica es una agravante afección para el sistema de salud pública. La detección y seguimiento oportuno de los factores desencadenantes y de progresión de la enfermedad son una prioridad en cada sistema de salud.  Objetivo:  Caracterizar la enfermedad renal crónica en pacientes con diabetes mellitus tipo2 con mal control metabólico.  Método: Se realizó un estudio descriptivo, de corte transversal en pacientes con diabetes mellitus tipo 2 que ingresaron al programa de enfermedad renal crónica del Hospital Dr. Docente Clínico Quirúrgico Dr. Miguel Enríquez desde octubre 2021 a enero 2023. El universo estuvo compuesto por 175 pacientes, de ellos, se seleccionó la muestra, 74 pacientes que cumplieron con los criterios de inclusión luego de firmar el consentimiento informado.  Resultados: Existió predominio de enfermedad renal crónica en pacientes jóvenes (64 % en 18 a 49 años); así mismo el sexo femenino representó el 65,3 %; y un tiempo de evolución de la diabetes mellitus tipo 2 de 1 a 5 años con 49,3 %; las comorbilidades más frecuentes fueron: dislipidemia, hipertensión arterial e insuficiencia cardiaca con una prevalencia de 89,3 %; 79,3 % y 41,3 % ; el estadio según el daño renal predominante fue el grado 2 con 20,0 %; el 4 % de los pacientes necesitó tratamiento renal sustitutivo.  Conclusiones:  La enfermedad renal suele progresar más en mujeres y en pacientes con múltiples factores de riesgo cardiovasculares. Se asocia a la progresión de la enfermedad renal el inadecuado control glucémico. El daño de la función renal depende en gran medida del control metabólico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Chronic kidney disease is an aggravating condition for the public health system.The detection and timely monitoring of the triggering and progression factors of the disease are a priority in each health system.  Objective:  To characterize chronic kidney disease in patients with type 2 diabetes mellitus with poor metabolic control.  Method:  A descriptive, cross-sectional study was carried out on patients with type 2 diabetes mellitus who entered the chronic kidney disease program of the Hospital &#8220;Dr. Miguel Enríquez&#8221; from October 2021 to January 2023. The population was made up of 175 patients; the sample selected was of 74 patients, who met the inclusion criteria after signing the informed consent.  Results:  There was a predominance of chronic kidney disease in young patients (64% in 18 to 49 years olds);likewise, the female sex represented a 65.3%;and a duration of type 2 diabetes mellitus of 1 to 5 years in 49.3 %; the most frequent comorbidities were: dyslipidemia, arterial hypertension and heart failure with a prevalence of 89. %,79.3% and 41.3% respectively. The predominant kidney damage stage was grade 2 in a 20.0%;4% of patients required renal replacement treatment.  Conclusions:  Kidney disease usually progresses more in women and in patients with multiple cardiovascular risk factors.Inadequate glycemic control is associated with the progression of kidney disease. Damage to kidney function largely depends on metabolic control.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  A doença renal crônica é um agravante para o sistema público de saúde. A detecção e monitorização atempada dos factores desencadeantes e de progressão da doença são uma prioridade em cada sistema de saúde.  Objetivo:  Caracterizar a doença renal crônica em pacientes com diabetes mellitus tipo 2 com mau controle metabólico.  Método:  Foi realizado um estudo descritivo e transversal com pacientes com diabetes mellitus tipo 2 que ingressaram no programa de doença renal crônica do Hospital &#8220;Dr. Miguel Enríquez&#8221; de outubro de 2021 a janeiro de 2023. O universo foi composto por 175 pacientes, de deles, a amostra foi selecionada, 74 pacientes que atenderam aos critérios de inclusão após assinatura do termo de consentimento livre e esclarecido.  Resultados:  Houve predomínio de doença renal crônica em pacientes jovens (64 % entre 18 e 49 anos),da mesma forma, o sexo feminino representou 65,3 %; e tempo de diabetes mellitus tipo 2 de 1 a 5 anos com 49,3 %; as comorbidades mais frequentes foram: dislipidemia, hipertensão arterial e insuficiência cardíaca com prevalência de 89,3 %, 79,3 % e 41,3 % respectivamente. O estágio de acordo com a lesão renal predominante foi grau 2 com 20,0 %; 4 % dos pacientes necessitaram de tratamento de substituição renal.  Conclusões:  A doença renal costuma progredir mais em mulheres e em pacientes com múltiplos fatores de risco cardiovascular.O controle glicêmico inadequado está associado à progressão da doença renal.Os danos à função renal dependem em grande parte do controle metabólico.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[enfermedad renal crónica]]></kwd>
<kwd lng="es"><![CDATA[progresión]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[chronic kidney disease]]></kwd>
<kwd lng="en"><![CDATA[progression]]></kwd>
<kwd lng="pt"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="pt"><![CDATA[doença renal crônica]]></kwd>
<kwd lng="pt"><![CDATA[progressão]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El gran reto del Gobierno en la salud pública de México: la nefropatía diabética cómo causa principal de enfermedad renal crónica]]></article-title>
<source><![CDATA[Gac Méd Bilbao]]></source>
<year>2020</year>
<volume>117</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>245-56</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruano]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Chil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ordóñez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hay de la Puente]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Siret]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gámez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de progresión de la enfermedad renal crónica en pacientes atendidos en una consulta de Nefrología comunitaria]]></article-title>
<source><![CDATA[Rev Méd Electrón]]></source>
<year>2023</year>
<volume>45</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iraizoz]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Brito]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Jaramillo]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detección de factores de riesgo de enfermedad renal crónica en adultos]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Int]]></source>
<year>2022</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rico]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Daza]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Raad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Montejo]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad renal diabética: puesta al día]]></article-title>
<source><![CDATA[Anal Fac Cienc Méd (Asunción)]]></source>
<year>2022</year>
<volume>55</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>86-98</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bover]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Goicoechea]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Cebollada]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Escalada]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Documento de información y consenso para la detección y manejo de la enfermedad renal crónica]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2022</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>223-362</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rosas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sebastián]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[ODC]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Documento de consenso sobre el uso de iSGLT2 en pacientes con enfermedad renal crónica y diabetes]]></article-title>
<source><![CDATA[Gac Méd Méx]]></source>
<year>2022</year>
<volume>158</volume>
<numero>72</numero>
<issue>72</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conde]]></surname>
<given-names><![CDATA[MBL]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[EAO]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[AO]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreiro]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Barrera]]></surname>
<given-names><![CDATA[MC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desarrollo de la enfermedad renal crónica en pacientes con hipertensión arterial y/o diabetes mellitus]]></article-title>
<source><![CDATA[Univ Méd Pinar]]></source>
<year>2019</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fong]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[TJMl]]></given-names>
</name>
<name>
<surname><![CDATA[Fong]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marcadores de daño renal en pacientes con factores de riesgo de enfermedad renal crónica]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2018</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>142-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Guerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad renal crónica, algunas consideraciones actuales]]></article-title>
<source><![CDATA[Multimed]]></source>
<year>2020</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Luk]]></surname>
<given-names><![CDATA[AOY]]></given-names>
</name>
<name>
<surname><![CDATA[Tam]]></surname>
<given-names><![CDATA[CHT]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Carstensen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[ESH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2019</year>
<volume>95</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>178-87</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Penno]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Solini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Orsi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bonora]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Fondelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Trevisan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study]]></article-title>
<source><![CDATA[BMC Med]]></source>
<year>2021</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Saucedo]]></surname>
<given-names><![CDATA[AL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolómica de la nefropatía diabética: tras la huella de indicadores de desarrollo y progresión]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2020</year>
<volume>40</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>585-96</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez García]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo Herrera]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Pedraza-Rodríguez]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Pupo Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación y aplicación de la escala de percepción del tratamiento con insulina en pacientes cubanos con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Endocrinol, Diab Nutr]]></source>
<year>2022</year>
<volume>69</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>791-801</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuentes]]></surname>
<given-names><![CDATA[GAE]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[YJJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lievanos]]></surname>
<given-names><![CDATA[MÁL]]></given-names>
</name>
<name>
<surname><![CDATA[Lechuga]]></surname>
<given-names><![CDATA[MGB.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Screening chronic kidney disease in long-standing diabetic patients at a primary care unit UMF 222]]></article-title>
<source><![CDATA[Rev Colom Nefrol]]></source>
<year>2022</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e543</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arana]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez]]></surname>
<given-names><![CDATA[SP.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a la enfermedad renal crónica en diabéticos tipo 2 atendidos de forma regular en un Hospital I]]></article-title>
<source><![CDATA[Rev Méd Trujillo]]></source>
<year>2020</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>153-62</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuevas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barlandas]]></surname>
<given-names><![CDATA[NRE]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La enfermedad renal oculta en la población diabética de Copalillo, Guerrero, México]]></article-title>
<source><![CDATA[Rev Iberoamer Cienc Salud]]></source>
<year>2022</year>
<volume>11</volume>
<numero>22</numero>
<issue>22</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balderas]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Legorreta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paredes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Andersson]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insuficiencia renal oculta y factores asociados en pacientes con enfermedades crónicas]]></article-title>
<source><![CDATA[Gac Méd Méx]]></source>
<year>2019</year>
<volume>156</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toapanta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Guirao]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Román]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Vergara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio piloto de seguimiento en pacientes con enfermedad renal diabética mediante la aplicación NORA]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2023</year>
<numero>1136</numero>
<issue>1136</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
<name>
<surname><![CDATA[Knicely]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Grams]]></surname>
<given-names><![CDATA[ME.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic Kidney Disease Diagnosis and Management]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2019</year>
<volume>322</volume>
<numero>13</numero>
<issue>13</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Azar]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Indicadores antropométricos y descontrol glucémico en diabetes tipo 2 con enfermedad renal]]></article-title>
<source><![CDATA[Rev Méd Inst Mex Seg Soc]]></source>
<year>2021</year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>313-21</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
